Freenome, Inc. (FRNM) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

Freenome, Inc. (FRNM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $120.6M, listed on NASDAQ, employing roughly 378 people, carrying a beta of 0.35 to the broader market. Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. Led by Aaron Elliott, public since 2026-07-21.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for FRNM as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →